CSF somatostatin increase in patients with early parkinsonian syndrome

1995 ◽  
Vol 9 (2-3) ◽  
pp. 189-196 ◽  
Author(s):  
A. Espino ◽  
M. Calopa ◽  
S. Ambrosio ◽  
J. Ortolà ◽  
J. Peres ◽  
...  
Keyword(s):  
Parkinsonian Syndrome

A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese

2009 ◽  
Vol 2009 ◽  
pp. 84-86
Author(s):  
N. Kumar
Keyword(s):  
Parkinsonian Syndrome

Experimental parkinsonian syndrome induced in rats by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1988 ◽  
Vol 105 (4) ◽  
pp. 470-474 ◽  
Author(s):  
G. N. Kryzhanovskii ◽  
M. A. Atadzhanov ◽  
V. A. Zagorevskii ◽  
L. M. Sharkova ◽  
T. A. Voronina ◽  
...  
Keyword(s):  
Parkinsonian Syndrome

Lymphocytes from mice with a 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine(MPTP)-induced parkinsonian syndrome reduce motor activity in C57Bl/6 mice

1994 ◽  
Vol 117 (3) ◽  
pp. 232-234 ◽  
Author(s):  
G. N. Kryzhanovskii ◽  
T. V. Davydova ◽  
V. G. Fomina ◽  
K. D. Pletsityi ◽  
V. A. Evseev ◽  
...  
Keyword(s):  
Motor Activity ◽  
Parkinsonian Syndrome

Effects of combination naloxone, cyclodolum and dipheninumon MPP+-induced Parkinsonian syndrome

1995 ◽  
Vol 31 ◽  
pp. 105
Author(s):  
M.A. Atadzhanov ◽  
A.R. Rakhimdzhonov
Keyword(s):  
Parkinsonian Syndrome

scholarly journals Assessment of Autonomic Function in Patients with a Parkinsonian Syndrome

BMJ ◽  
1971 ◽  
Vol 4 (5779) ◽  
pp. 80-84 ◽  
Author(s):  
M. J. Aminoff ◽  
C. S. Wilcox
Keyword(s):  
Autonomic Function ◽  
Parkinsonian Syndrome

EYE SYMPTOMS AND THE PARKINSONIAN SYNDROME

1929 ◽  
Vol 2 (5) ◽  
pp. 555-559 ◽  
Author(s):  
L. J. GOLDBACH
Keyword(s):  
Parkinsonian Syndrome ◽  
Eye Symptoms

Clinical Trials of Transergan in the Parkinsonian Syndrome

2009 ◽  
Vol 154 (5) ◽  
pp. 375-379 ◽  
Author(s):  
SVEN ELIASSON ◽  
STIG TEJNING
Keyword(s):  
Clinical Trials ◽  
Parkinsonian Syndrome

Utility of Follow-up Dopamine Transporter SPECT With 123I-FP-CIT in the Diagnostic Workup of Patients With Clinically Uncertain Parkinsonian Syndrome

2017 ◽  
Vol 42 (8) ◽  
pp. 589-594 ◽  
Author(s):  
Ivayla Apostolova ◽  
Daulat S. Taleb ◽  
Axel Lipp ◽  
Imke Galazky ◽  
Dennis Kupitz ◽  
...  
Keyword(s):  
Dopamine Transporter ◽  
Diagnostic Workup ◽  
Parkinsonian Syndrome

scholarly journals Parkinsonian Syndrome as a Neurological Manifestation of Behcet's Disease

1998 ◽  
Vol 25 (1) ◽  
pp. 82-85 ◽  
Author(s):  
D. Bogdanova ◽  
I. Milanov ◽  
D. Georgiev
Keyword(s):  
Basal Ganglia ◽  
Brain Stem ◽  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Parkinsonian Syndrome ◽  
Periventricular White Matter ◽  
Pseudobulbar Palsy ◽  
Muscle Rigidity ◽  
Behcet's Disease

ABSTRACT:Background:The central nervous system is often involved in Behcet's disease. Most common are meningoencephalitic and brain stem syndromes. Although basal ganglia involvement is not an uncommon finding on necropsy, there are only single reports on extrapyramidal syndromes-dyskinesia, chorea and Parkinsonism in patients with Behcet's disease.Case study:We report a patient fulfilling the criteria of the International Study Group for Behcet's disease. He had recurrent oral ulcerations, bilateral posterior uveitis and retinal vasculitis, skin papules and pustules, and recurrent monoarthritis. Neurologic examination revealed pseudobulbar palsy, slight and asymmetric bilateral pyramidal syndrome, muscle rigidity involving the four limbs, bradykinesia, masked face, and impaired postural reflexes. There was postural tremor in the extremities and myoclonic jerks involving the tongue and face muscles. Magnetic resonance imaging demonstrated small bilateral multifocal hyperintense lesions, with right predilection, involving the periventricular white matter, brain stem and basal ganglia.Conclusions:The Parkinsonian syndrome found in our patient might be due to involvement of both substantia nigra and basal ganglia. This case further emphasizes the wide spectrum of the neurological manifestations of Behcet's disease

Sign in / Sign up

Export Citation Format

Share Document